According to ICH GCP, who besides the sponsor should approve the financial aspects of a clinical trial?
ICH E6(R2) 5.6.1: ''The sponsor should ensure agreement from the investigator/institution on the financial aspects of the trial.''
This ensures transparency in compensation, reimbursement, and budget.
Currently there are no comments in this discussion, be the first to comment!